Atlas Trials

Core Cerebrospinal Fluid Biomarker Profile in Anti-Leucine Rich Glioma Inactivated 1 (Anti-LGI1) Encephalitis

Clinical trial NCT04001270 · UNKNOWN

Trial details

NCT number
NCT04001270
Sponsor
Hospices Civils de Lyon
Status
UNKNOWN
Study type
OBSERVATIONAL
EncephalitisLGI1 Antibody Associated Encephalitis
Start date
2019-07-15
Primary completion
2019-08-15
Enrollment
24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.